$1.39
-0.075-5.14%
Last update: Nov 4, 3:10 PM
MaxCyte Inc
MXCTNASDAQ
The average analyst price target for MaxCyte is $7.75, 459.6% above the current price. Of 5 analysts, 3 rate it Buy and 2 Hold. Targets range from $5 to $11. The latest change came on Mar 25, 2026, when Craig-Hallum lowered its price target on MaxCyte from $7 to $5 and kept a Buy rating.
Price Target Range — 6 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
